Recurrent and founder mutations in the Netherlands: the cardiac phenotype of founder mutations p.S13F and p.N342D
Autor: | E. F. Ippel, A. J. van der Kooi, A. van den Wijngaard, Esther Brusse, J. P. van Tintelen, K. Y. van Spaendonck-Zwarts, M.P. van den Berg, Jessica E. Hoogendijk, Ludolf G. Boven, W. C. Yee, J. D. H. Jongbloed, Pieter A. Doevendans, M. de Visser |
---|---|
Přispěvatelé: | Ethical, Legal, Social Issues in Genetics (ELSI), Cardiovascular Centre (CVC), Cell biology, Neurology, Pediatric Surgery, MUMC+: DA KG Lab Centraal Lab (9), Klinische Genetica, Genetica & Celbiologie, RS: CARIM School for Cardiovascular Diseases, Human Genetics, Amsterdam Neuroscience, Other departments |
Jazyk: | angličtina |
Rok vydání: | 2012 |
Předmět: |
Cardiomyopathy
FAMILIES Desmin Cardiac conduction disease Special Article SKELETAL MYOPATHY medicine Medicine & Public Health Genetics Myopathy Founder mutation Gene Medicine/Public Health general DESMIN MYOPATHY business.industry medicine.disease Skeletal myopathy GENE BLOCK medicine.symptom Cardiology and Cardiovascular Medicine business Cardiac phenotype Founder effect |
Zdroj: | Netherlands Heart Journal, 20(5), 219-228. Bohn, Stafleu, Van Loghum Netherlands Heart Journal Netherlands Heart Journal, 20(5), 219-228. Bohn Stafleu van Loghum Netherlands heart journal, 20(5), 219-228. Bohn Stafleu van Loghum |
ISSN: | 1876-6250 1568-5888 |
Popis: | Background Desmin-related myopathy (DRM) is an autosomally inherited skeletal and cardiac myopathy, mainly caused by dominant mutations in the desmin gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac phenotype of all carriers, and the founder effects. Methods We collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using genealogy and haplotype analysis. Results We identified three new index patients carrying the p.S13F mutation and two new families carrying the p.N342D mutation. In total, we summarised the clinical details of 39 p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardiac phenotype of p.S13F carriers is fully penetrant and severe, characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement. Although muscle weakness is a prominent and presenting symptom in p.N342D carriers, their cardiac phenotype is similar to that of p.S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haplotype analysis. Conclusion DRM may occur as an apparently isolated cardiological disorder. The cardiac phenotypes of the DES founder mutations p.S13F and p.N342D are characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement. Electronic supplementary material The online version of this article (doi:10.1007/s12471-011-0233-y) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |